Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development expenses	$ 4,212,918	$ 4,527,698	$ 10,043,918	$ 11,231,862
General and administrative expenses	3,410,433	4,156,606	6,685,191	7,550,069
Total operating expenses	7,623,351	8,684,304	16,729,109	18,781,931
Loss from operations	(7,623,351)	(8,684,304)	(16,729,109)	(18,781,931)
Interest income (expenses), net
Interest income	333,624	675,209	711,473	1,344,104
Interest expense	(2,144,481)	(1,187,971)	(3,075,359)	(2,362,716)
Interest income (expenses), net	(1,810,857)	(512,762)	(2,363,886)	(1,018,612)
Loss before income taxes	(9,434,208)	(9,197,066)	(19,092,995)	(19,800,543)
Benefit from income taxes	0	869,169	1,169,820	869,169
Net loss	(9,434,208)	(8,327,897)	(17,923,175)	(18,931,374)
Comprehensive loss	$ (9,434,208)	$ (8,327,897)	$ (17,923,175)	$ (18,931,374)
Per share information:
Net loss per share, basic (in dollars per share)	$ (0.21)	$ (0.23)	$ (0.41)	$ (0.53)
Net loss per share, diluted (in dollars per share)	$ (0.21)	$ (0.23)	$ (0.41)	$ (0.53)
Weighted average common shares outstanding, basic (in shares)	45,902,502	36,693,561	43,226,618	35,754,715
Weighted average common shares outstanding, diluted (in shares)	45,902,502	36,693,561	43,226,618	35,754,715